Apnetem

Phosphoricum Acidum, Alumen, Phosphorus, Senega Officinalis, Adenosinum Cyclophosphoricum, Antimonium Tartaricum, Grindelia, Sabadilla, Alumina, Cuprum Metallicum, Sanguinarinum Nitricum, Silicea, Lachesis Mutus, Rheum (palmatum), Zincum Metallicum, Lycopodium Clavatum, Manganum Phosphoricum, Antipyrinum, Coenzyme A

Nucleic Products, Llc
Human Otc Drug
NDC 75053-0008

Apnetem also known as Phosphoricum Acidum, Alumen, Phosphorus, Senega Officinalis, Adenosinum Cyclophosphoricum, Antimonium Tartaricum, Grindelia, Sabadilla, Alumina, Cuprum Metallicum, Sanguinarinum Nitricum, Silicea, Lachesis Mutus, Rheum (palmatum), Zincum Metallicum, Lycopodium Clavatum, Manganum Phosphoricum, Antipyrinum, Coenzyme A is a human otc drug labeled by 'Nucleic Products, Llc'. National Drug Code (NDC) number for Apnetem is 75053-0008. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Apnetem drug includes Adenosine Cyclic Phosphate - 9 [hp_X]/mL Aluminum Oxide - 12 [hp_X]/mL Antimony Potassium Tartrate - 9 [hp_X]/mL Antipyrine - 18 [hp_X]/mL Coenzyme A - 12 [hp_C]/mL Copper - 12 [hp_X]/mL Grindelia Hirsutula Flowering Top - 9 [hp_X]/mL Lachesis Muta Venom - 12 [hp_X]/mL Lycopodium Clavatum Spore - 13 [hp_X]/mL Manganese Phosphate, Dibasic - 15 [hp_X]/mL and more. The currest status of Apnetem drug is Active.

Drug Information:

Drug NDC:	75053-0008
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Apnetem
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Phosphoricum Acidum, Alumen, Phosphorus, Senega Officinalis, Adenosinum Cyclophosphoricum, Antimonium Tartaricum, Grindelia, Sabadilla, Alumina, Cuprum Metallicum, Sanguinarinum Nitricum, Silicea, Lachesis Mutus, Rheum (palmatum), Zincum Metallicum, Lycopodium Clavatum, Manganum Phosphoricum, Antipyrinum, Coenzyme A
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Nucleic Products, Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ADENOSINE CYCLIC PHOSPHATE - 9 [hp_X]/mL ALUMINUM OXIDE - 12 [hp_X]/mL ANTIMONY POTASSIUM TARTRATE - 9 [hp_X]/mL ANTIPYRINE - 18 [hp_X]/mL COENZYME A - 12 [hp_C]/mL COPPER - 12 [hp_X]/mL GRINDELIA HIRSUTULA FLOWERING TOP - 9 [hp_X]/mL LACHESIS MUTA VENOM - 12 [hp_X]/mL LYCOPODIUM CLAVATUM SPORE - 13 [hp_X]/mL MANGANESE PHOSPHATE, DIBASIC - 15 [hp_X]/mL Load more... PHOSPHORIC ACID - 6 [hp_X]/mL PHOSPHORUS - 9 [hp_X]/mL POLYGALA SENEGA ROOT - 9 [hp_X]/mL POTASSIUM ALUM - 6 [hp_X]/mL RHEUM PALMATUM ROOT - 12 [hp_X]/mL SANGUINARINE NITRATE - 12 [hp_X]/mL SCHOENOCAULON OFFICINALE SEED - 9 [hp_X]/mL SILICON DIOXIDE - 12 [hp_X]/mL ZINC - 12 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	18 May, 2021
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	22 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Nucleic Products, LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
NUI:	M0005152 N0000175831 N0000008595 N0000008924 N0000175830
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	E0399OZS9N LMI26O6933 DL6OZ476V3 T3CHA1B51H SAA04E81UX 789U1901C5 IDB0NAZ6AI VSW71SS07I C88X29Y479 VZ3U1H7Q5B Load more... E4GA8884NN 27YLU75U4W M7T6H7D4IF 1L24V9R23S G025DAL7CE BOP122S791 6NAF1689IO ETJ7Z6XBU4 J41CSQ7QDS
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:	Copper-containing Intrauterine Device [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:	Decreased Embryonic Implantation [PE] Decreased Sperm Motility [PE] Inhibit Ovum Fertilization [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:	Copper [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:	Copper [CS] Copper-containing Intrauterine Device [EPC] Decreased Embryonic Implantation [PE] Decreased Sperm Motility [PE] Inhibit Ovum Fertilization [PE] Magnetic Resonance Contrast Activity [MoA] Paramagnetic Contrast Agent [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
75053-0008-1	118 mL in 1 BOTTLE, DROPPER (75053-0008-1)	18 May, 2021	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Apnetem

Phosphoricum Acidum & more..

Liquid
Nucleic Products, LLC
NDC: 75053-0008

Purpose:

Indications: homeopathic medicine for the minor relief of fatigue, headache, disordered sleep, sore throat and dry mouth. claims based on homeopathic theory, not accepted medical evidence. not fda evaluated.

Product Elements:

Apnetem phosphoricum acidum, alumen, phosphorus, senega officinalis, adenosinum cyclophosphoricum, antimonium tartaricum, grindelia, sabadilla, alumina, cuprum metallicum, sanguinarinum nitricum, silicea, lachesis mutus, rheum (palmatum), zincum metallicum, lycopodium clavatum, manganum phosphoricum, antipyrinum, coenzyme a phosphoric acid phosphoric acid potassium alum aluminum hydroxide phosphorus phosphorus polygala senega root polygala senega root adenosine cyclic phosphate adenosine cyclic phosphate antimony potassium tartrate antimony cation (3+) grindelia hirsutula flowering top grindelia hirsutula flowering top schoenocaulon officinale seed schoenocaulon officinale seed aluminum oxide aluminum oxide copper copper sanguinarine nitrate nitrate ion silicon dioxide silicon dioxide lachesis muta venom lachesis muta venom rheum palmatum root rheum palmatum root zinc zinc lycopodium clavatum spore lycopodium clavatum spore manganese phosphate, dibasic manganese cation (2+) antipyrine antipyrine coenzyme a coenzyme a water alcohol

Indications and Usage:

Warnings:

Warnings: if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away. do not use if seal is broken or missing. this product does not contain sugar, starch, salt, preservatives, artificial flavors or additives, and no wheat, gluten, soy or milk derivatives. warning - severe or persistent sore throat or sore throat accompanied by high fever, headach, nausea, and vomiting may be serious. consult physicians promptly. do not use more than 2 days or administer to children under 3 years of age unless directed by physician.

Dosage and Administration:

Directions: place drops under tongue 30 minutes before/after meals. adults and children 12 years and over: take one full dropper up to 2 times a day. consult a physician for use in children under 12 years of age.

Package Label Principal Display Panel:

Packaging label display: ndc: 75053-0008-1 nu cleic apnetem homeopathic medicine for professional use only 4 fl oz. (118 ml) apnetem

Further Questions:

Questions: distributed by: nucleic products, llc po box 7148 grove, ok 74344

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.